Modulating metals as a therapeutic strategy for Alzheimer's disease.

@article{Hung2012ModulatingMA,
  title={Modulating metals as a therapeutic strategy for Alzheimer's disease.},
  author={Lin W Hung and Kevin Jeffrey Barnham},
  journal={Future medicinal chemistry},
  year={2012},
  volume={4 8},
  pages={955-69}
}
In 1906, Alois Alzheimer first characterized the disease that bears his name. Despite intensive research, which has led to a better understanding of the pathology, there is no effective treatment for this disease. Of the drugs approved by the US FDA, none are disease modifying, only symptomatic. Unfortunately, there have been a number of failed clinical trials in the past 10 years where studies show either no cognitive improvement or, worse, serious side effects associated with treatment. Hence… CONTINUE READING